Lodinews.com

default avatar
Welcome to the site! Login or Signup below.
|
||
Logout|My Dashboard

'Tune-In' to Glioblastoma during Brain Cancer Awareness Month

Print
Font Size:
Default font size
Larger font size

Posted: Wednesday, May 7, 2014 10:00 pm | Updated: 1:34 am, Wed Sep 17, 2014.

(BPT) - Interested in using social media for a good cause? Look no further. In recognition of Brain Cancer Awareness Month this May, Twitter users everywhere can support glioblastoma (GBM) patients through the Tune-In to GBM campaign by tweeting the #TuneIn2GBM hashtag from May 1, 2014 through May 31, 2014. GBM is the most common and deadly form of primary brain cancer and affects approximately 10,000 Americans each year. The exact cause of GBM is not known.

The Cancer Support Community, the Chris Elliott Fund, the LIVESTRONG Foundation and the Musella Foundation, four non-profit organizations dedicated to supporting brain cancer patients and their families, are partnering with Novocure to help raise awareness about GBM by providing valuable information about GBM, available support and currently approved treatment options.

“We are very proud of the way the Tune-In to GBM campaign brings together the brain cancer community to support patients and families who are fighting this deadly disease,” said Peter Melnyk, Chief Commercial Officer of Novocure. “We are thrilled to partner with and support these four wonderful patient advocacy organizations to raise awareness about this deadly disease, and look forward to hearing from people who are “tuning in” to GBM this month and throughout the year.”

For valuable information on GBM, including educational resources for patients and caregivers, visit TuneIn2GBM.com and Tune-In to GBM by tweeting the #TuneIn2GBM hashtag throughout the month of May.

Novocure is a private oncology company pioneering a novel therapy for solid tumors called NovoTTFTM Therapy. Novocure’s U.S. operations are based in Portsmouth, NH and New York, NY. Additionally, Novocure has offices in Switzerland and Japan and a research center in Haifa, Israel. For additional information about Novocure, please visit www.novocure.com.

Rules of Conduct

  • 1 Use your real name. You must register with your full first and last name before you can comment. (And don’t pretend you’re someone else.)
  • 2 Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually oriented language.
  • 3 Don’t threaten. Threats of harming another person will not be tolerated.
  • 4 Be truthful. Don't lie about anyone or anything. Don't post unsubstantiated allegations, rumors or gossip that could harm the reputation of a person, company or organization.
  • 5 Be nice. No racism, sexism or any sort of -ism that is degrading to another person.
  • 6 Stay on topic. Make sure your comments are about the story. Don’t insult each other.
  • 7 Tell us if the discussion is getting out of hand. Use the ‘Report’ link on each comment to let us know of abusive posts.
  • 8 Share what you know, and ask about what you don't.
  • 9 Don’t be a troll.
  • 10 Don’t reveal personal information about other commenters. You may reveal your own personal information, but we advise you not to do so.
  • 11 We reserve the right, at our discretion, to monitor, delete or choose not to post any comment. This may include removing or monitoring posts that we believe violate the spirit or letter of these rules, or that we otherwise determine at our discretion needs to be monitored, not posted, or deleted.

Welcome to the discussion.

Poll

Loading…

Your News

News for the community, by the community.

Mailing List

Subscribe to a mailing list to have daily news sent directly to your inbox.

  • Breaking News

    Would you like to receive breaking news alerts? Sign up now!

  • News Updates

    Would you like to receive our daily news headlines? Sign up now!

  • Sports Updates

    Would you like to receive our daily sports headlines? Sign up now!

Manage Your Lists